Yoshiki Sakaguchi Selected Research

Fibrin Tissue Adhesive (Fibrin Sealant)

4/2019	Endoscopic shielding with polyglycolic acid sheets and fibrin glue for a large-sized ulcer after endoscopic submucosal dissection.
1/2019	Endoscopic tissue shielding to prevent bleeding after endoscopic submucosal dissection: a prospective multicenter randomized controlled trial.
1/2016	Triamcinolone Injection and Shielding with Polyglycolic Acid Sheets and Fibrin Glue for Postoperative Stricture Prevention after Esophageal Endoscopic Resection: A Pilot Study.
4/2015	Polyglycolic acid sheets and fibrin glue decrease the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms (with video).
4/2015	Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection.
1/2015	Preventing esophageal stricture after endoscopic submucosal dissection: steroid injection and shielding with polyglycolic acid sheets and fibrin glue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiki Sakaguchi Research Topics

Disease

7	Stomach Neoplasms (Stomach Cancer) 08/2021 - 01/2014
4	Hemorrhage 01/2019 - 01/2014
3	Pathologic Constriction (Stenosis) 12/2020 - 04/2015
3	Infections 05/2014 - 01/2013
2	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 05/2013
2	Ulcer 04/2019 - 01/2019
2	Adenoma (Adenomas) 02/2019 - 10/2018
2	Neoplasms (Cancer) 02/2019 - 05/2013
2	Adenocarcinoma 02/2019 - 05/2013
2	Atrophic Gastritis 07/2016 - 01/2014
2	Esophageal Stenosis (Esophageal Stricture) 04/2015 - 01/2015
2	Heartburn (Pyrosis) 01/2014 - 01/2013
1	Sarcopenia 01/2022
1	Atrophy 08/2021
1	Gastritis 08/2021
1	Carcinoma (Carcinomatosis) 12/2020
1	Carcinogenesis 02/2019
1	Peptic Esophagitis (Reflux Esophagitis) 01/2018
1	Gastroesophageal Reflux (GERD) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Hemorrhagic Shock 07/2016
1	Diverticulum 01/2015
1	Gallstones (Gallstone) 05/2014
1	Body Weight (Weight, Body) 05/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Weight Gain 01/2014
1	Carcinosarcoma 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 01/2014
1	Sleep Deprivation 01/2014
1	Dyspepsia (Indigestion) 01/2014
1	Lymphatic Metastasis 05/2013

Drug/Important Bio-Agent (IBA)

6	Polyglycolic Acid (Polyglycolide)IBA 12/2020 - 01/2015
6	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 04/2019 - 01/2015
4	Prostaglandins AIBA 12/2020 - 04/2015
3	BariumIBA 08/2021 - 01/2014
3	AcidsIBA 07/2016 - 01/2013
3	Pepsinogen A (Pepsinogen)IBA 05/2014 - 01/2013
2	SteroidsIBA 12/2020 - 01/2015
1	Carmine (Natural Red 4)IBA 10/2020
1	Coloring Agents (Dyes)IBA 10/2020
1	Differentiation AntigensIBA 07/2019
1	Genetic Markers (Genetic Marker)IBA 02/2019
1	CateninsIBA 02/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2019
1	APTIBA 10/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2016
1	Indigo Carmine (Indigo Blue)IBA 06/2016
1	Triamcinolone (Aristocort)FDA Link 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Guanosine Triphosphate (GTP)IBA 05/2014
1	oxidized low density lipoproteinIBA 05/2014
1	Pepsinogen CIBA 05/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Proton Pump InhibitorsIBA 01/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2014
1	Indicators and Reagents (Reagents)IBA 05/2013

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2014
1	Length of Stay 01/2022
1	Endoscopic Hemostasis 07/2016
1	Drug Therapy (Chemotherapy) 01/2014
1	Gastrectomy 01/2014
1	Esophagectomy 05/2013